MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05059ntm a2200337 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MY-KuUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20261007092717.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
t||||fr|||| 000 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
261005t20262026my a|||fr|||| 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
THE0010811 (Local) |
| Qualifying information |
Hardback |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMPSA |
| Language of cataloging |
eng |
| Transcribing agency |
UMPSA |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
FSTI .F38 2026 r Thesis |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nur Fatini Ilyana Mohamat Johari, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Silver nanoparticles-edible bird nest embedded nanofibre for wound healing agent / |
| Statement of responsibility, etc. |
Nur Fatini Ilyana Mohamat Johari |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Kuantan, Pahang : |
| Name of producer, publisher, distributor, manufacturer |
UMPSA, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2026 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
© 2026 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 168 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
30 cm. + |
| Accompanying material |
1 CD-ROM. |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| Source |
rda |
| File type |
text file |
| Encoding format |
PDF |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Faculty of Industrial Sciences and Technology |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Thesis (Master of Science) -- Universiti Malaysia Pahang - 2026 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Include bibliographical reference |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Research on biomaterials in the form of nanofibers for tissue engineering has seen significant growth, primarily because these materials closely mimic the extracellular matrix (ECM), which supports cell attachment, differentiation, and proliferation. This study focuses on edible bird’s nest (EBN), a natural substance known for its longstanding medicinal properties, as the core material for nanofiber development. EBN contains bioactive compounds that enhance nanoparticle formation and promote cell differentiation. The objective of this research is to develop nanofibers composed of EBN integrated with silver nanoparticles (AgNPs) for applications in skin tissue engineering. Electrospinning, a technique capable of producing nanometer-scale fibers with interconnected pores resembling ECM structure, was employed for fiber fabrication. This report is divided into two main sections. The first part covers the fabrication and characterization of the nanofibers, while the second focuses on cell culture and animal studies using both the nanofibers and EBN solution. In the first phase, five different EBN concentrations (3–7%) were used to synthesize AgNPs. The Ag-EBN solution was characterized using Ultraviolet visible (UV-Vis) spectrophotometry, Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrophotometer (LC-QTOF MS), and Field Emission Electron Microscope (FESEM). An absorption peak at 460 nm indicated the presence of AgNPs via surface plasmon resonance. LC-QTOF MS identified Citrusin C, a phenolic compound in EBN, as the agent responsible for reducing and stabilizing AgNPs. The nanoparticles measured between 17 and 35 nm in diameter. The optimized Ag-EBN solution was mixed with 10 wt% polyvinyl alcohol (PVA) in a 20:80 ratio and electrospun to produce smooth nanofibers. To render the nanofibers water-insoluble, they were chemically crosslinked using glutaraldehyde. The nanofibers’ microstructure, morphology, mechanical, and thermal properties were analyzed using FESEM, Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR), X-ray Diffraction (XRD), ultimate tensile strength (UTM), and Thermogravimetric analysis (TGA). ATR-FTIR results indicated possible interactions between Ag-EBN and PVA. FESEM revealed fiber diameters ranging from 75 to 100 nm. XRD analysis showed a peak shift from 19.70° for pure PVA and observed shift peak with Ag-EBN, indicating structural changes. TGA/DTGA curves displayed distinct weight-loss stages across different fiber concentrations. The highest Young’s modulus was observed at 6% Ag-EBN, indicating improved in fibre stiffness. The biological properties, including antibacterial activity and in vitro wound healing, were also assessed. Notably, 7% Ag-EBN/PVA nanofibers exhibited the strongest antibacterial effect against Staphylococcus aureus. However, when tested in a 96-well plate for in vitro wound closure, AgNP-containing nanofibers were found to be cytotoxic to myocytes, showing no wound healing activity. The second part of the study explored in vitro and in vivo evaluations of EBN solution, EBN/PVA nanofibers, and PVA nanofibers. Wound healing assay were assessed using live imaging microscopy. Among the tested formulations, 5% EBN/PVA nanofibers achieved the highest wound closure after 24 hours, indicating excellent cell compatibility due to PVA incorporation. For the in vivo study, diabetic rats were treated with the different formulations to monitor wound reduction. After 14 days, the group treated with 5% EBN/PVA nanofibers showed complete wound healing compared to the other groups. Histological analysis confirmed re-epithelialization across all treated wounds. These findings suggest that the biocompatible EBN-based nanofibers hold great potential for use in next-generation tissue-engineered wound dressings. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Faculty of Industrial Sciences and Technology |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Universities and colleges |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Theses |
| General subdivision |
Dissertations |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Thesis |